Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • EXTRAORDINARY GENERAL MEETING 27 SEPTEMBER 2022
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November 2020
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Rights issue 2022
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • Analyst
  • IR Contact
  • Presentations

Management

Thomas Warthoe

Thomas Warthoe

CEO, CO-FOUNDER

Number of shares: 1 521 053
Warrants series TO2: 14 000

Entrepreneur with over 20 years of experience in the healthcare industry (and specifically diagnostics). Thomas has founded and developed three biotech companies. In two of the companies Thomas founded, Display System Biotech and Ampligon, successful exits were made. He has successfully entered strategic partnerships and licensing agreements with global diagnostic companies such as Backman Coulter, Shionogi Co and Omron Healthcare over the years.

Employed in Qlife Aps since founding 2018

Maiken Worsøe Rosenstierne

DIRECTOR R&D

Employee options: 30 000

Maiken is a Biochemist with an MSc and PhD Career: Postdoc at University of Copenhagen and at Roskilde University. Maiken was previously a Senior Scientist at Statens Serum Institut and is a respected scientist and a solid leader of multiple R&D projects and our large R&D department.

Kristina Christensen

DIRECTOR QA/RA

Kristina has extensive experience in IVD and Medical Devices within the areas of Quality Assurance, Design Control, Risk Management, Product Development of reagents and instruments and clinical evaluations.

Kasper Boel Rousøe

CFO

Number of shares: 28 500
Warrant series TO2: 28 500
Employee options: 120 000

Kasper joined Qlife on March 1, 2022, bringing more than 20 years of experience from leading roles in the financial area. Kasper hold a M. Sc. in Economics from Copenhagen University and an EMBA from IMD in Lausanne, Switzerland.

 

 

 

         
         
         

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health
Last published: 2022-08-15

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.